Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Public T cell receptors confer high-avidity CD4 responses to HIV controllers
Daniela Benati, … , Fernando Arenzana-Seisdedos, Lisa A. Chakrabarti
Daniela Benati, … , Fernando Arenzana-Seisdedos, Lisa A. Chakrabarti
Published April 25, 2016
Citation Information: J Clin Invest. 2016;126(6):2093-2108. https://doi.org/10.1172/JCI83792.
View: Text | PDF
Research Article AIDS/HIV Article has an altmetric score of 136

Public T cell receptors confer high-avidity CD4 responses to HIV controllers

  • Text
  • PDF
Abstract

The rare patients who are able to spontaneously control HIV replication in the absence of therapy show signs of a particularly efficient cellular immune response. To identify the molecular determinants that underlie this response, we characterized the T cell receptor (TCR) repertoire directed at Gag293, the most immunoprevalent CD4 epitope in the HIV-1 capsid. HIV controllers from the ANRS CODEX cohort showed a highly skewed TCR repertoire that was characterized by a predominance of TRAV24 and TRBV2 variable genes, shared CDR3 motifs, and a high frequency of public clonotypes. The most prevalent public clonotypes generated TCRs with affinities at the higher end of values reported for naturally occurring TCRs. The high-affinity Gag293-specific TCRs were cross-restricted by up to 5 distinct HLA-DR alleles, accounting for the expression of these TCRs in HIV controllers of diverse genetic backgrounds. Transfer of these TCRs to healthy donor CD4+ T cells conferred high antigen sensitivity and polyfunctionality, thus recapitulating key features of the controller CD4 response. Transfer of a high-affinity Gag293-specific TCR also redirected CD8+ T cells to target HIV-1 capsid via nonconventional MHC II restriction. Together, these findings indicate that TCR clonotypes with superior functions are associated with HIV control. Amplification or transfer of such clonotypes may contribute to immunotherapeutic approaches aiming at a functional HIV cure.

Authors

Daniela Benati, Moran Galperin, Olivier Lambotte, Stéphanie Gras, Annick Lim, Madhura Mukhopadhyay, Alexandre Nouël, Kristy-Anne Campbell, Brigitte Lemercier, Mathieu Claireaux, Samia Hendou, Pierre Lechat, Pierre de Truchis, Faroudy Boufassa, Jamie Rossjohn, Jean-François Delfraissy, Fernando Arenzana-Seisdedos, Lisa A. Chakrabarti

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Total
Citations: 1 2 4 8 9 6 1 4 7 1 43
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2021 (9)

Title and authors Publication Year
The discriminatory power of the T cell receptor
J Pettmann, A Huhn, EA Shah, MA Kutuzov, DB Wilson, ML Dustin, SJ Davis, PA van der Merwe, O Dushek
eLife 2021
Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions
J Kervevan, LA Chakrabarti
International journal of molecular sciences 2021
Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells
K Sugata, Y Matsunaga, Y Yamashita, M Nakatsugawa, T Guo, L Halabelian, Y Ohashi, K Saso, MA Rahman, M Anczurowski, CH Wang, K Murata, H Saijo, Y Kagoya, D Ly, BD Burt, MO Butler, TW Mak, N Hirano
Nature Biotechnology 2021
Clustering based approach for population level identification of condition-associated T-cell receptor β-chain CDR3 sequences
DA Yohannes, K Kaukinen, K Kurppa, P Saavalainen, D Greco
BMC bioinformatics 2021
Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients
TH Nguyen, M Koutsakos, CE van de Sandt, JC Crawford, L Loh, S Sant, L Grzelak, EK Allen, T Brahm, EB Clemens, M Auladell, L Hensen, Z Wang, S Nüssing, X Jia, P Günther, AK Wheatley, SJ Kent, M Aban, YM Deng, KL Laurie, AC Hurt, S Gras, J Rossjohn, J Crowe, J Xu, D Jackson, LE Brown, NL Gruta, W Chen, PC Doherty, SJ Turner, TC Kotsimbos, PG Thomas, AC Cheng, K Kedzierska
Nature Communications 2021
Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort
L Plaçais, F Boufassa, C Lécuroux, E Gardiennet, V Avettand-Fenoel, A Saez-Cirion, O Lambotte, N Noël
2021
Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures
YH Teng, HS Quah, L Suteja, JM Dias, A Mupo, RJ Bashford-Rogers, GS Vassiliou, ML Chua, DS Tan, DW Lim, NG Iyer
Cancer Immunology, Immunotherapy 2021
Autophagy-dependent glutaminolysis drives superior IL21 production in HIV-1-specific CD4 T cells
H Loucif, X Dagenais-Lussier, D Avizonis, L Choinière, C Beji, L Cassin, JP Routy, JH Fritz, D Olagnier, J van Grevenynghe
Autophagy 2021
Distinct antibody profiles in HLA-B ∗ 57 + , HLA-B ∗ 57 − HIV controllers and chronic progressors
J Klingler, N Paul, G Laumond, S Schmidt, L Mayr, T Decoville, O Lambotte, B Autran, S Bahram, C Moog
AIDS 2021

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 15 news outlets
Blogged by 3
Posted by 6 X users
Referenced in 5 patents
On 2 Facebook pages
Referenced in 1 Wikipedia pages
Mentioned in 1 Google+ posts
Highlighted by 1 platforms
94 readers on Mendeley
See more details